TREM2 and diabetes mellitus: Another study demonstrated that TREM-2 suppresses inflammatory responses by negatively regulating the p38 MAPK signaling pathway, alleviating neuroinflammation and cognitive impairment caused by the combined effects of diabetes mellitus (DM) and chronic cerebral hypoperfusion (CCH) on the organism (91).